Skip to content

Vaginal Misoprostol and Foley Catheter for Induction of Labor

Sequential Versus Concurrent Use of Vaginal Misoprostol Plus Foley Catheter for Induction of Labor

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02952807
Enrollment
160
Registered
2016-11-02
Start date
2016-01-31
Completion date
2017-02-28
Last updated
2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labor Affected Fetus / Newborn

Brief summary

to compare between sequential and concurrent use of vaginal misopristol plus foleys catheter for induction of labor

Detailed description

two groups of patients who are eligible for labor induction were randomized to either sequential use of vaginal misopristol plus foleys catheter or concurrent use of vaginal misopristol plus foleys catheter.

Interventions

DRUGMisoprostol

vaginal Misoprostol Plus Foley Catheter

DEVICEFoley Catheter

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Indication for labour induction Term pregnancy with alive fetus Bishop score less than five

Exclusion criteria

* Age less than 18 years Previous uterine scar Nonvertex presentation Non-reassuring fetal status Fetal anomalies Fetal growth restriction Genital bleeding Tumors, malformations and/or ulcers of vulva, perineum or vagina

Design outcomes

Primary

MeasureTime frameDescription
induction delivery interval (time from starting induction to delivery)48hourssafety issue

Secondary

MeasureTime frameDescription
Number of doses needed to bring on labour48hsafety issue
Failed induction (failure to elicit contraction after 72 hours)72hsafety issue
Hyperstimulation syndrome24hsafety issue
Need of oxytocin for augmentation of labour48hsafety issue
Severe neonatal morbidity or perinatal death28 dayssafety issue
Serious maternal morbidity or maternal death42 dayssafety issue
Cesarean section72hsafety issue

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026